Francesco Casuscelli

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Kinase Inhibitors. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Casuscelli. Retrieved from https://idiyas.com/inventor/francesco-casuscelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 71.4

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Milan, IT (2012)
Nerviano, IT (2013)
Dairago (MI), IT (2014)
Dairago, IT (2012 - 2016)
Dairago Milan, IT (2024)

Company Filing History:

14 out of 139

Nerviano Medical Sciences S.r.l.

patents

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

IDH Inhibitors

Heterocyclic Compounds

Kinase Inhibitors

Pyrrolo Derivatives

Tricyclic Compounds

Protein Kinase Modulators

Antitumor Agents

Neurodegenerative Agents

Pyrazolyl-Pyrimidine

Substituted Derivatives

Bicyclic Pyrazole

Triazolo Pyrimidine

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12521395 - Gem-disubstituted heterocyclic compounds and their use as IDH inhibitors (2026-01-13),

2. 12018023 - Heterocondensed pyridones compounds and their use as IDH inhibitors (2024-06-25),

3. 9309253 - Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors (2016-04-12),

4. 9284298 - Pyrazolyl-pyrimidine derivatives as kinase inhibitors (2016-03-15),

5. 9181258 - Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors (2015-11-10),

6. 9145418 - Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors (2015-09-29),

7. 8981092 - Substituted 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-ones as modulators of protein kinase activity (2015-03-17),

8. 8975267 - Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors (2015-03-10),

9. 8916577 - Tricyclic derivatives, process for their preparation and their use as kinase inhibitors (2014-12-23),

10. 8580783 - [1,2,4]triazolo [1,5-c]pyrimidine derivatives as Hsp90 modulators (2013-11-12),

11. 8541576 - Substituted pyrazolo-quinazoline derivatives as kinase inhibitors (2013-09-24),

12. 8394802 - 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases (2013-03-12),

13. 8309578 - Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents (2012-11-13),

14. 8207180 - Tricyclic indoles and (4,5-dihydro) indoles (2012-06-26),

Title: The Innovative Journey of Francesco Casuscelli

Introduction: Francesco Casuscelli, a talented inventor hailing from Dairago, Italy, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Francesco Casuscelli's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and a sustainable energy-saving device designed to reduce carbon footprint.

Career Highlights: With a background in electrical engineering, Francesco Casuscelli has a successful career marked by numerous achievements. He has received recognition for his innovative solutions in renewable energy, IoT devices, and advanced robotics.

Collaborations: Francesco Casuscelli has collaborated with leading tech companies and research institutions to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have reshaped industries.

Conclusion: Francesco Casuscelli's passion for innovation and commitment to creating a sustainable future have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.